PFIZER INC

PFE

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001225208-26-003315
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Denton David M (CFO)
SEC Filing link

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions ⓘ

Transaction 1

Security

Stock Appreciation Rights

Action

Grant

Date

2026-03-03

Code

A

Net shares

+216,537.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

216,537.0

Filing's footnotes

1. The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.